Christoph Zielinski named editor-in-chief of ESMO Open

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

CHRISTOPH ZIELINSKI was named editor-in-chief of ESMO Open, a new open-access, peer-reviewed online journal published by the European Society of Medical Oncology.

Zielinski, 63, is director of the Clinical Division of Oncology and Chairman of the Department of Medicine I and the Comprehensive Cancer Centre at the Medical University in Vienna.

He has been president of the Central European Cooperative Oncology Group since 1999 and member of the ESMO executive board since 2014.

Zielinski’s research focuses on clinical trials in breast, lung cancer, personalized medicine and immuno-oncology. He has published more than 600 papers.

ESMO Open will operate a fast submission and review process with continuous publication online to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer-review process.

The first articles will be published in January 2016.

Table of Contents

YOU MAY BE INTERESTED IN

In this episode of The Cancer Letter Podcast, Fran Visco, president of the National Breast Cancer Coalition, and Jacquelyn Cobb, managing editor of The Cancer Letter, discuss the Metastatic Breast Cancer Act, bipartisan legislation that would eliminate the waiting periods for Social Security Disability Insurance and Medicare for eligible people with metastatic breast cancer. 
Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login